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Abstract
The amyloid precursor protein (APP) is well known for giving rise to the amyloid-b peptide and for its role in Alzheimer’s
disease. Much less is known, however, on the physiological roles of APP in the development and plasticity of the central
nervous system. We have used phage display of a peptide library to identify high-affinity ligands of purified recombinant
human sAPPa695 (the soluble, secreted ectodomain from the main neuronal APP isoform). Two peptides thus selected
exhibited significant homologies with the conserved extracellular domain of several members of the semaphorin (Sema)
family of axon guidance proteins. We show that sAPPa695 binds both purified recombinant Sema3A and Sema3A
secreted by transfected HEK293 cells. Interestingly, sAPPa695 inhibited the collapse of embryonic chicken (Gallus gallus
domesticus) dorsal root ganglia growth cones promoted by Sema3A (Kd#8?10
29 M). Two Sema3A-derived peptides
homologous to the peptides isolated by phage display blocked sAPPa binding and its inhibitory action on Sema3A
function. These two peptides are comprised within a domain previously shown to be involved in binding of Sema3A to
its cellular receptor, suggesting a competitive mechanism by which sAPPa modulates the biological action of
semaphorins.
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Introduction
The amyloid precursor protein (APP) family members are
ubiquitously expressed type I integral membrane proteins with
relatively large extracellular domains and short intracellular
domains. In the central nervous system (CNS), APP can be
cleaved to generate the amyloid-b peptide (Ab), which forms
oligomers and amyloid plaques that accumulate in the limbic and
cerebral cortices of Alzheimer’s disease (AD) patients. It is now
widely accepted that Ab aggregates are the main neurotoxins
that lead to synapse damage and neuronal dysfunction in AD
[1,2]. However, it is also possible that loss or disruption of
physiological function(s) of APP and the underlying signal
transduction pathways contribute to or initiate the pathological
process in AD.
The physiological functions of APP have been subject of in-
tense investigation and several lines of evidence suggest that APP
regulates neurite outgrowth. Indeed, APP synthesis and axonal
transport coincide with periods of axon elongation and synapse
formation [3,4]. The secreted extracellular domain of APP,
sAPPa, acts as a growth factor for many cell types and promotes
neuritogenesis in post-mitotic neurons [5]. Consistent with a
physiological role for APP in neuron development [6,7], secreted
APP fragments and overexpression of transmembrane APP have
both been shown to increase neurite outgrowth [8–10], whereas
decreased APP expression alters process outgrowth [6,11–12] and
APP knock-out mice exhibit motor dysfunction and brain gliosis
[6]. Moreover, recent data showed that a complex including APP,
FE65 and an additional unknown protein is involved in neurite
outgrowth at early stages of neuronal development [13]. However,
the mechanisms by which APP regulates neurite outgrowth remain
largely unknown.
Growing axons are guided to their targets by extracellular
physical and molecular cues [14]. Such cues may have positive or
negative effects on growth cone motility as they bind to surface
receptors and trigger reorganization of cytoskeletal components
underlying cone dynamics [15]. In developing tissues, growth
cones simultaneously encounter multiple guidance cues and, there-
fore, the resulting cone behavior reflects integration of signaling by
multiple cues [16]. Various molecules have been shown to have
inhibitory activities on axonal growth during development [17]
and to cause growth cone collapse or neurite repulsion in vitro.
Among those molecules, semaphorins comprise the largest gene
family of axonal growth inhibitory molecules [18].
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brane-bound proteins that are expressed in most tissues in a
developmentally-regulated pattern. Semaphorins are dynamically
expressed in the CNS during embryonic development and their
expression is often associated with growing axons. Expression
decreases with maturity and several observations indicate that in
adult brain the expression of secreted semaphorins is sensitive to
electrical activity and experience [18]. The functional role of
semaphorins in guiding axon projections is well established and
more recent evidence points to additional roles in a variety of
cellular events, including neuronal migration [19–20], cell death
by apoptosis [21], dendritic guidance and spine formation [22–
23], axon pruning [24], axonal transport [25] and synaptic
transmission [26–27]. Semaphorins exert the majority of their
effects by binding to cognate receptor proteins through their
extracellular domains. A common theme is that semaphorin-
triggered signaling induces the rearrangement of the actin and
microtubule cytoskeleton. Mutations in semaphorin genes are
linked to several human neurological disorders, but their precise
influence on the pathogenesis of such diseases remains to be
determined.
With the goal of identifying novel neuronal ligands for APP, we
have used phage display of a peptide library to identify peptides
that bind to purified recombinant human sAPPa695 (the soluble
ectodomain from the main neuronal isoform of APP, APP695).
Using this approach, we isolated 2 heptapeptides that bind to
sAPPa695 and are highly homologous to several members of the
human semaphorin family. We show that sAPPa695 binds with
high affinity to semaphorin 3A (Sema3A) and inhibits the collapse
of chicken dorsal root ganglia (DRG) growth cones induced by
Sema3A. These results provide the first evidence that APP
regulates neurite outgrowth through interaction with members of
the semaphorin family and open new avenues for characterization
of novel physiological functions of APP.
Materials and Methods
Ethics statement
All experiments involving animals were approved by and
carried out in accordance with the guidelines of the Institutional
Animal Care and Use Committee of the Federal University of Rio
de Janeiro (permit number IBCCF-035), and all efforts were made
to minimize suffering.
Reagents
Recombinant human sAPPa695 was produced and purified as
described [28]. Anti-APP antibody was MAB348 from Chemicon
(Temecula, CA) and recombinant Sema3A and anti-Sema3A were
from R&D Systems (Minneapolis, MN). All peptides were
synthesized by New England Peptides (Gardner, MA).
Sema3A-AP conditioned medium
Human embryonic kidney 293 (HEK293) cells transfected with
expression vectors for Sema3A conjugated to alkaline phosphatase
(Sema3A-AP) [29] were kindly provided by Dr. Daniela R. Uziel
(Federal University of Rio de Janeiro). Sema3A-AP-transfected or
control non-transfected HEK293 cells were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM; Invitrogen, Carlsbad, CA)
supplemented with 10% fetal bovine serum (FBS, Invitrogen),
100 U/ml penicillin and 2 mM glutamine (Invitrogen) in a
humidified 5% CO2 atmosphere at 37uC. Prior to experiments,
cells were cultured in DMEM/10% FBS for 2 days and the
conditioned control medium or medium containing Sema3A-AP
were collected, filtered and stored at 220uC until used.
Biopanning against sAPPa695
Screening of the phage display peptide library was performed as
previously described [30–32]. Briefly, sAPPa695 was diluted to
0.1 mg/ml in PBS and 50 ml aliquots were incubated under con-
stant shaking for 16 h in the wells of a 96-well plate at 4uC. The
wells were then blocked with 0.5% bovine serum albumin (Sigma)
in PBS for 1 h and 10 ml of a phage display library (PhD-C7C;
New England Biolabs, Ipswich, MA) were added to each well. All
further procedures were carried out exactly according to manu-
facturer’s instructions. sAPPa695-binding phages were individually
picked, amplified, and had their DNA sequenced. A heptapeptide
with amino acid sequence LRSHPLG was expressed by 5 out of
28 sAPPa695-binding clones. Another peptide with amino acid
sequence TFASVMT was expressed by an additional sAPPa695-
binding clone. The amino acid sequences of the two peptides were
compared with protein sequences deposited in several data banks
(NCBI) using BLAST [33].
Binding of Sema3A to sAPPa695
Fifty or 100 ng of sAPPa695 (as indicated in ‘‘Results’’) in 50 ml
of PBS were added to wells in a 96-well plate and were incubated
overnight at 4uC. Wells were then washed with PBS and blocked
for 2 h with 1% BSA in PBS. Different concentrations of purified
recombinant Sema3A in PBS containing 0.5% BSA or Sema3A-
AP-containing conditioned medium were added to the wells and
incubated overnight at 4uC with agitation. The wells were washed
six times with PBS, incubated with anti-Sema3A for 1 h, washed,
incubated with horseradish peroxidase-conjugated secondary
antibody for 1 h and developed with SuperSignal ELISA Femto
Substrate (Pierce, Rockford, IL). When Sema3A-AP was used,
binding was directly evaluated by determining alkaline phospha-
tase activity with p-nitrophenyl phosphate (Sigma) as substrate.
In another set of experiments, sAPPa695 was biotinylated
using the EZ-LinkSulfo-NHS-Biotin reagent (Pierce, Rockford,
IL) and added at different concentrations to wells that had
been previously coated with 50 ng recombinant Sema3A and
blocked with 1% hen egg-white lysozyme (Sigma) instead of
BSA, in order to avoid the binding of sAPPa695 to BSA. Non-
specific binding was determined in the presence of 100-fold
excess non-biotinylated sAPPa695. The wells were washed six
times with PBS, incubated with horseradish peroxidase-conju-
gated streptavidin (Sigma) for 1 h and developed with Super-
Signal ELISA Femto Substrate. Each experiment was performed
in triplicate.
Pull-down and immunoprecipitation experiments
Streptavidin-coupled Dynabeads (Invitrogen) were incubated
with biotinylated sAPPa695 (bAPP) for 1 h, washed with PBS
and then incubated for 2 h with Sema3A-AP-containing condi-
tioned medium or control medium (conditioned by non-transfect-
ed HEK293 cells). After washing the beads, binding was evaluated
by measuring phosphatase activity using p-nitrophenyl phosphate.
Alternatively, protein A-Sepharose beads (Amersham GE) were
incubated at 4uC with anti-Sema3A plus 120 ml of Sema3A-AP-
containing conditioned medium or 120 ml of control medium and
300 ng of bAPP. Immunoprecipitation was conducted in the
presence or in the absence of the ARSHPAM and LTASLLI
peptides (as described in ‘‘Results’’). The beads were then washed
six times with PBS containing 0.1% Nonidet P40 (Sigma) and the
immunoprecipitated material was separated by SDS-PAGE.
Protein bands were transferred to nitrocellulose and the mem-
brane was probed with horseradish peroxidase-conjugated strep-
tavidin and developed with SuperSignal Femto Substrate.
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Dorsal root ganglia (DRG) were dissected from E7 chick
embryos as previously described [34]. Ganglia explants were
cleaned, cut in halves or quarters and plated at low density on
poly-L-lysine- and laminin-coated 4-well tissue culture dishes
(Nalge Nunc, Rochester, NY). DMEM containing 10% fetal calf
serum with gentamycin (10 mg/ml) was supplemented with 20 ng/
ml NGF 2.5S (Sigma). For immunohistochemistry experiments,
the medium was additionally supplemented with 75 nM sAPP,
0.8 nM Sema3A and/or 75 nM of the ARSHPAM and LTASLLI
peptides (see ‘‘Results’’) before plating. Cultures were kept for 24 h
at 37uC in a humidified 5% CO2 incubator. Samples were fixed
with 4% paraformaldehyde, permeabilized with 0.25% Triton X-
100 for 5 min and labeled for neurofilaments [35] using mouse
monoclonal antibody 3A10 (Hybridoma Bank, University of Iowa)
and Alexa488-conjugated rabbit anti-mouse IgG (Invitrogen). For
quantification of growth cone morphology by phase contrast,
Sema3A, sAPP and/or peptides were added 30 min before
fixation.
Randomly selected fields at the border of the ganglia were
imaged either by fluorescence or by phase contrast microscopy on
a Zeiss Axiovert microscope. All images were collected using 206
or 406objectives, and the contrast in phase contrast images was
automatically adjusted using NIH ImageJ software [36]. For each
image, the number of axonal endings was scored by one of two
different experimentators as either a growing growth cone with
lamellipodia and filopodia or a collapsed cone (a tapered axonal
terminal without spread lamellipodia or less than three filopodia).
Seven independent experiments were performed with different
ganglion cultures. The percentage of collapsed growth cones for
each ganglion and means 6 SEM for each experimental condition
were calculated (control: n=7 ganglia; sAPPa: n=4; peptides:
n=9; Sema3A: n=19; Sema3A+sAPPa: n=15; Sema3A+sAP-
Pa+peptides: n=9).
The minimum adequate generalized linear binomial model
[37,38] showed significant differences (p,0.001) between results
obtained in one group of conditions (control, sAPPa and Sema3A
+sAPPa) and another group of conditions (Sema3A and Sema3A
+sAPPa+peptides). Furthermore, Bonferroni-corrected p values for
multiple comparisons between conditions are indicated in the
legend to the figure.
Results
Semaphorins as sAPPa ligands
In order to identify putative sAPPa ligands, we initially screened
a phage display peptide library and selected clones that bound
specifically to sAPPa695. Five out of 28 individually picked sAPPa-
binding clones contained the peptide sequence LRSHPLG. An
additional sAPPa-binding clone comprising amino acid sequence
TFASVMT was isolated. The sequences of both peptides were
then compared to human protein sequences in the NCBI databank
using BLAST [33]. This analysis revealed that both peptides
presented significant sequence homologies to several members of
the human semaphorin protein family (Fig. 1A). Interestingly, the
TFASVMT peptide is homologous to a region of semaphorin 3A
(Fig. 1B) that has been shown to be important for receptor
recognition [39,40], while the region that is homologous to the
LRSHPLG peptide lies very close to that same important site.
These initial results suggested that sAPPa binds to semaphorins at
a domain that is important for receptor recognition and biological
activity.
sAPPa binds to Sema3A
In order to investigate the interaction between sAPPa and
semaphorin, we performed direct in vitro binding assays using
semaphorin3A of different origins. First, we immobilized sAPPa695
on microplate wells and added different concentrations of purified
Figure 1. sAPPa-binding peptides selected by phage display are homologous to members of the human semaphorin family. (A)
Sequence alignment of the LRSHPLG and TFASVMT peptides with members of the human semaphorin family; identical residues are shown in red and
conservative amino acid replacements are in blue. Sequence alignment was performed using ClustALL [56] (B) Ribbon representation of the structure
of the receptor binding module of Semaphorin 3A. The amino acid sequences homologous to the LRSHPLG (blue; ARSHPAM) and TFASVMT (red;
LTASLLI) peptides are highlighted. Residues involved in receptor specificity [39] are shown in yellow and red. The figure was generated using RasMol
and the atomic coordinates for Sema3A (Protein Data Bank accession code 1Q47; ref. 40).
doi:10.1371/journal.pone.0022857.g001
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protein commercially available at the time) or BSA (as a negative
control) and probed with anti-Sema3A antibody. This assay
revealed that Sema3A binds specifically to sAPPa (Fig. 2A). Next,
we performed a similar experiment using conditioned medium
from HEK293 cells transfected with Sema3A conjugated to
alkaline phosphatase (Sema3A-AP). Addition of increasing con-
centrations of conditioned medium containing Sema3A-AP caused
a dose-dependent binding of semaphorin to sAPPa (Fig. 2B), while
no specific binding was detected when control medium (not
containing Sema3A) was used. Furthermore, Sema3A-AP incu-
bated with biotinylated sAPPa (bAPP) could be specifically
precipitated by streptavidin-coated beads (Fig. 2C). Taken
together, these results demonstrate binding of sAPPa to Sema3A
using three different approaches.
sAPPa modulates semaphorin function
Because sAPPa was found to interact with Sema3A, we asked
whether nanomolar concentrations of sAPPa might interfere with
Sema3A-induced collapse of DRG axonal growth cones. As
expected, DRG neurons showed extensive neurites after 24 hours
in culture in the presence of NGF [41] (Fig. 3A,E). Addition of
0.8 nM Sema3A caused massive growth cone collapse (Fig. 3B,F,I).
Remarkably, co-application of 75 nM sAPPa695 together with
Sema3A inhibited the collapse of most growth cones (Fig. 3C,G,I).
To further confirm the specificity of binding and the identity of the
putative binding site on Sema3A, we synthesized the peptides
within Sema3A that are homologous to the peptides identified
by phage display. As shown in Fig. 1A, amino acid sequences
ARSHPAM and LTASLLI in Sema3A are homologous to the
LRSHPLG and TFASVLT peptides, respectively. Interestingly,
both ARSHPAM and LTASLLI peptides blocked the inhibition
by sAPPa of Sema3A-induced growth cone collapse (Fig. 3D,H,I),
suggesting that inhibition is indeed due to direct and specific
interaction between sAPPa and Sema3A at the binding site
defined by the two peptides.
While our data do not permit calculating a simple affinity
constant between sAPPa and Sema3A due to the possibility of
higher-orderinteractionsbetweentheproteinsoradditionalbinding
partners in living cells, it is possible to estimate an upper limit for the
dissociation constant based on the findingthat the biological activity
of0.8 nMSema3Ais completely blocked by75 nMsAPPa (Fig. 3I).
Assuming that Sema3A and sAPPa bind in a 1:1 stoichiometry and
that #10% of Sema3A remains unbound in the presence of
this concentration of sAPPa, the dissociation constant Kd is #
8?10
29 M. Presence of higher order binding complexes would
imply an even higher affinity between the two proteins.
Discussion
Several studies suggest roles for APP in neurite outgrowth and
synaptogenesis, but the detailed molecular interactions that mediate
the functions of APP during neuronal development are largely
unknown (for a review, see ref. 5). A major current unknown is the
identity of the neuronal receptors that mediate the physiological
functions of sAPPa. Identification of such receptors would provide
insight into the physiological roles of sAPPa and, possibly, into
mechanisms of pathogenesis in AD. Using phage display of peptide
libraries [30–32], we have now identified a number of peptides that
bind sAPPa and are homologous to neuronal receptors putatively
involved in sAPPa interactions. We report here on two heptapep-
tides that are homologous to regions in the extracellular domains of
several members of the human semaphorin (Sema) family of
proteins. Based on this homology, we set out to investigate the
interaction between sAPPa695 and Sema3A.
Sema3A is a secreted protein that signals growth cone col-
lapse, chemorepulsion and neuronal apoptosis during early CNS
Figure 2. Semaphorin 3A specifically binds sAPPa. (A) Wells in a 96-well plate were coated with either 50 ng sAPPa695 (APP), 1 mg BSA or 50 ng
Semaphorin 3A (Sema3A), blocked with 1% BSA and overlayed with different concentrations of Sema3A or sAPPa695 (as indicated below the lanes).
After washing, binding was determined by probing with anti-Sema3A antibody. The graph shows concentration-dependent binding of Sema3A to
sAPPa695 by densitometric quantification of the immunodots using NIH Image J. Bars represent averages of three independent experiments
performed in triplicate each. The blot illustrates a representative experiment. (B) Wells in a 96-well plate were coated with 100 ng sAPPa695 (APP),
blocked with 1% BSA and incubated with increasing volumes of conditioned medium containing alkaline phosphatase-conjugated Semaphorin 3A
(Sema3A-AP). After washing, binding was determined by measuring alkaline phosphatase activity. Bars represent averages of three independent
experiments performed in triplicate. (C) Streptavidin-coated beads were incubated with biotinylated sAPPa695 (bAPP) and Sema3A-AP-conditioned
medium or control (non-transfected) medium. After washing, binding was evaluated by measuring alkaline phosphatase activity associated with the
beads. Bars represent averages of three independent experiments.
doi:10.1371/journal.pone.0022857.g002
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binds to Sema3A and inhibits the collapse of chicken DRG growth
cones triggered by Sema3A. Interestingly, synthetic peptides
corresponding to the amino acid sequences in Sema3A homolo-
gous to the peptides identified by phage display (ARSHPAM and
LTASLLI) blocked both the binding of sAPPa695 to Sema3A and
the inhibitory effect of sAPPa on Sema3A-induced growth cone
collapse. These results suggest that sAPPa binds to a site near the
region defined by the ARSHPAM and LTASLLI amino acid
sequences in Sema3A.
In harmony with our findings, it has been shown that the
extracellular domain of sAPPa695, containing the amino acid
sequence RERMS (amino acid residues 328–332), induces neurite
outgrowth and neuronal survival [42]. Using an affinity column
containing bound RERMS peptide, collapsin response mediator
protein 2 (CRMP-2) was identified as a potential sAPPa695 receptor
[43]. CRMP-2 is an important downstream intracellular mediator
of Sema3A signaling and the high affinity binding of CRMP-2 to
sAPPa695 suggests a functional interaction of sAPPa with the
semaphorin receptor complex. Although it is tempting to speculate
that interaction with Sema3A may involve the RERMS domain of
sAPPa, this question remains open for further investigation.
A recent study showed that sAPPa and full-length membrane-
bound APP can each interact biochemically and functionally
with integrin beta I to mediate neurite outgrowth [44], while
sAPPa also directly binds to and dissociates dimers of full-length
membrane-bound APP [45]. The signaling pathways of sema-
phorins and integrins are closely linked, and integrin activation/
inhibition is central to signaling of different members of the
semaphorin family [46]. Of particular interest, Sema3A inhibits
integrin beta 1 signaling and promotes growth cone collapse [47].
Significantly, inhibition of integrin beta I function was also shown
to block the outgrowth-enhancing effects of sAPPa [44]. Our data
indicate that sAPPa may also interact with other members of the
semaphorin family in addition to Sema3A, suggesting that sAPPa/
semaphorin complexes may regulate multiple aspects of neuronal
development and function.
It was recently shown that APP interacts with contactins 3 and 4
and associates with neuronglia cell adhesion molecule (NgCAM) in
retinal axons growing into the optic tectum of embryonic chick
brain [48]. Functional assays revealed regulatory effects of both
APP and contactin 4 on NgCAM-dependent growth of cultured
retinal axons. However, the mechanisms of binding of APP to
those ligands are still unclear, and it is unknown whether other
ligands or receptors are involved in the interactions.
While a role for Sema3A in axon guidance during develop-
ment has emerged from several studies, its functions in the adult
nervous system are not as well understood. Studies concerning the
localization of secreted semaphorins revealed that Sema3A is tran-
sported in secretory vesicles that move towards axonal terminals,
and this rapid microtubule-dependent transport is responsive to
neuronal activity [49]. In contrast, in dendritic compartments,
vesicles containing Sema3A appear more or less stationary. These
data support the idea that activity-dependent release of secreted
semaphorins occurs at synaptic sites in vivo. Interestingly, APP is also
transported in vesicles along axons by a fast, kinesin-dependent
anterograde transport mechanism [50]. Moreover, overexpression
of APP in Drosophila larvae induces impairment of axonal transport
of vesicles together with abnormalities in synaptic plasticity [51].
APP has recently been shown to interact with diverse synaptic
proteins [52–55], and semaphorin-APP interactions may also play a
role in the regulation of synaptic transmission and plasticity.
In conclusion, results presented here show that secreted APP
interacts with different members of the semaphorin family,
revealing a role for APP in regulating axon growth and guidance.
These findings may pave the way for elucidation of novel functions
of APP in normal CNS development as well as in physiological
and pathological mechanisms of plasticity.
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Figure 3. sAPPa modulates the biological activity of Sema3A. Growth cone morphology was examined in control chick DRG explants (A,E)
and in explants challenged for 30 minutes with 0.8 nM Sema3A (B,F), Sema3A+75 nM sAPPa695 (C,G) or Sema3A+sAPPa695+75 nM each of peptides
ARSHPAM and LTASLLI (D,H). After fixation and neurofilament immunostaining, growth cone morphology was examined using fluorescence (upper
panels) or phase contrast microscopy (lower panels). Scale bars: 10 mm. Representative images (A–H) illustrate on average two growth cones, but
more than 700 growth cones were evaluated in each experimental condition. Panel I shows results of quantitative analysis of the percentage of
collapsed growth cones (as determined from phase contrast images) in each experimental condition. Bars correspond to means 6 SEM of different
ganglia. Each experimental condition was replicated 3–6 times in independent experiments using different DRG cultures. Asterisks represent
statistically significant differences (**p,0.01; ***p,0.001; ANOVA followed by Bonferroni post-hoc test).
doi:10.1371/journal.pone.0022857.g003
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